1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Companion Animal Health Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Animal Type
6.1 Dogs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cats
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Equine
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Product
7.1 Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Pharmaceuticals
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Feed Additives
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Diagnostics
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Point-of-care Testing/In-house Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Veterinary Hospitals and Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agrolabo S.p.A.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Boehringer Ingelheim
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Ceva Santé Animale
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Dechra Pharmaceuticals PLC
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Elanco Animal Health Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 IDEXX Laboratories Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Indian Immunologicals Limited (National Dairy Development Board)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck & Co. Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Norbrook Laboratories
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Vetoquinol SA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Virbac
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Zoetis Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
世界のコンパニオンアニマルヘルス市場予測2023年-2028年 |
| 【英語タイトル】Companion Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
 | ・商品コード：IMARC23AP143 ・発行会社（調査会社）：IMARC ・発行日：2023年2月21日 ・ページ数：143 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：ヘルスケア |
| Single User | USD2,999 ⇒換算￥449,850 | 見積依頼/購入/質問フォーム |
| Five User | USD3,999 ⇒換算￥599,850 | 見積依頼/購入/質問フォーム |
| Enterprisewide | USD4,999 ⇒換算￥749,850 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| IMARC社の本調査レポートでは、2022年に234億ドルであった世界のコンパニオンアニマルヘルス市場規模が、2028年までに390億ドルに拡大し、予測期間中にCAGR8.4%で成長すると予想しています。本書は、コンパニオンアニマルヘルスの世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、動物別（犬、猫、馬、その他）分析、製品別（ワクチン、医薬品、飼料添加物、診断、その他）分析、エンドユーザー別（ポイントオブケアテスト/インハウステスト、動物病院・診療所、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況などの項目を整理しています。また、本書には、Agrolabo S.p.A.、Boehringer Ingelheim、Ceva Santé Animale、Dechra Pharmaceuticals PLC、Elanco Animal Health Incorporated、IDEXX Laboratories Inc.、Indian Immunologicals Limited (National Dairy Development Board)、Merck & Co. Inc.、Norbrook Laboratories、Vetoquinol SA、Virbac and Zoetis Inc.などの企業情報が含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のコンパニオンアニマルヘルス市場規模：動物別 - 犬における市場規模 - 猫における市場規模 - 馬における市場規模 - その他における市場規模 ・世界のコンパニオンアニマルヘルス市場規模：製品別 - ワクチンの市場規模 - 医薬品の市場規模 - 飼料添加物の市場規模 - 診断の市場規模 - その他の市場規模 ・世界のコンパニオンアニマルヘルス市場規模：エンドユーザー別 - ポイントオブケアテスト/インハウステストにおける市場規模 - 動物病院・診療所における市場規模 - その他における市場規模 ・世界のコンパニオンアニマルヘルス市場規模：地域別 - 北米のコンパニオンアニマルヘルス市場規模 - アジア太平洋のコンパニオンアニマルヘルス市場規模 - ヨーロッパのコンパニオンアニマルヘルス市場規模 - 中南米のコンパニオンアニマルヘルス市場規模 - 中東・アフリカのコンパニオンアニマルヘルス市場規模 ・SWOT分析 ・バリューチェーン分析 ・ポーターズファイブフォース分析 ・価格分析 ・競争状況 |
The global companion animal health market size reached US$ 23.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028.
Companion animal health refers to the regular monitoring of the health of companion animals to detect diseases and other conditions, which can put their lives in danger if left untreated. It includes the development of monoclonal antibody therapies, therapeutic vaccines, anti-neoplastic drugs, genomic tests, and digital technologies. At present, there is a significant rise in the number of pet parents around the world who are aware about the overall health and well-being of companion animals and routinely seek veterinary services.
Companion Animal Health Market Trends:
Companion animal aging has led to a rise in the risk of tumors, obesity, osteoarthritis, cardiovascular diseases (CVDs), diabetes mellitus, and hepatic and renal diseases worldwide. This, in confluence with the growing awareness about the One Health (OH) approach initiative, which recognizes that public health is connected with animal health and the environment, represents one of the key factors creating a positive outlook for the market. This initiative is supported by the World Health Organization (WHO), Food and Agriculture Organization (FAO), and the American Veterinary Medical Association (AVMA). Moreover, having companion animals is associated with positive health benefits, including lower blood pressure, decrease anxiety, reduce cardiac arrhythmia, more psychological stability, and better well-being. Besides this, there is an increase in the utilization of animal-assisted therapy in numerous areas of human health care. This, coupled with the rising population of traditional companion animals, such as dogs and cats, is impelling the market growth. Apart from this, vaccination of companion animals, particularly dogs, against rabies helps prevent the disease in animals and humans. Furthermore, the increasing prevalence of zoonotic diseases across the globe is anticipated to facilitate the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global companion animal health market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on animal type, product and end user.
Breakup by Animal Type:
Dogs
Cats
Equine
Others
Breakup by Product:
Vaccines
Pharmaceuticals
Feed Additives
Diagnostics
Others
Breakup by End User:
Point-of-care Testing/In-house Testing
Veterinary Hospitals and Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agrolabo S.p.A., Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Norbrook Laboratories, Vetoquinol SA, Virbac and Zoetis Inc.
Key Questions Answered in This Report
1. What was the size of the global companion animal health market in 2022?
2. What is the expected growth rate of the global companion animal health market during 2023-2028?
3. What has been the impact of COVID-19 on the global companion animal health market?
4. What are the key factors driving the global companion animal health market?
5. What is the breakup of the global companion animal health market based on the animal type?
6. What is the breakup of the global companion animal health market based on the end user?
7. What are the key regions in the global companion animal health market?
8. Who are the key players/companies in the global companion animal health market?
❖ レポートの目次 ❖
| ★調査レポート[世界のコンパニオンアニマルヘルス市場予測2023年-2028年] (コード：IMARC23AP143)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のコンパニオンアニマルヘルス市場予測2023年-2028年]についてメールでお問い合わせ |
